Table 4 In-dwell characteristics and adverse events of PORT-inserted patients, stratified by solid tumours versus haematological malignancies

Total catheter days

8226

29,071

–

–

–

CD per patient, median (IQR)

181 (63)

175 (69)

–

–

0.496

Mortality, n (%)

7 (12.5)

36 (17.9)

0.7

0.3–1.6

0.416

Days to death median (IQR)

100 (111)

67 (76)

–

–

0.1

DVT, n (%)

4 (7.1)

2 (1.0)

7.3

1.3–40.1

0.021

DVT/1000 CD

0.49

0.07

–

–

–

Days to DVT median (IQR)

15(36)

85 (−)

–

–

–

All catheter infections, n (%)

4 (7.1)

9 (4.5)

1.6

0.5–5.3

0.42

Infection/1000 CD

0.49

0.31

–

–

–

Local infection, n (%)

3 (5.4)

9 (4.5)

1.2

0.3–4.5

0.766

CRI, n (%)

3 (5.4)

3 (1.5)

–

–

0.12

CRBSI, n (%)

3 (5.4)

2 (1.0)

5.5

0.9–33.1

0.061

CRBSI/1000 CD

0.36

0.07

–

–

–

Days to infection median (IQR)

23 (37)

56 (85)

–

–

0.643

Haematoma, n (%)

3 (5.4)

10 (5.0)

–

–

1.0

Antibiotics, n (%)

26 (46.4)

22 (10.1)

–

–

< 0.001

Mechanical, n (%)

3 (5.4)

6 (3.0)

1.8

0.5–7.3

0.398

Mechanical/1000 CD

0.36

0.21

–

–

–

Days to mechanical event, median (IQR)

4 (−)

16 (57)

–

–

0.604

Occlusion, n (%)

8 (14.3)

18 (9.0)

1.6

0.7–3.7

0.256

Occlusion/1000 CD

0.97

0.62

–

–

–

Days to occlusion, median (IQR)

39 (144)

17 (43)

–

–

0.317

All grade adverse events, n (%)

21 (37.5)

37 (18.4)

1.8

1–3.2

0.053

All grade adverse events/1000 CD

2.55

1.27

–

–

–

Days to all grade adverse events, median (IQR)

26 (82)

22 (63)

–

–

0.64